Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients have?
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients has 44 citations in the OpenAlex counts ScholarIQ stores.
When was Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients published?
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients has 2021 year in the ScholarIQ index.
What is the open-access status of Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients?
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients has gold oa status in the ScholarIQ index.
What is the DOI of Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients?
The DOI for Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients is on the source record.
What is the PMID of Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients?
The PMID for Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients is on the source record.
What is the OpenAlex record for Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients?
The OpenAlex for Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients is on the source record.